OTC: PMCUF - Pro Medicus Limited

Rentabilidade por seis meses: +70.42%

Cronograma de promoção Pro Medicus Limited

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software.

mais detalhes
It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

EBITDA 0.0365
EV/EBITDA 72.64
Industry Health Care Technology
P/BV 38.47
P/E 99.14
P/S 37.84
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 0.0714
Див.доход ао 0.4677
Дивиденд ао 0.2466
Сайт https://www.promed.com.au
Цена ао 63.7
Число акций ао 0.10459 млрд
Alteração de preço por semana: -3.53% (163.775)
Alteração de preço por mês: +5.33% (150)
Alteração de preço em 3 meses: +31.67% (120)
Mudança de preço em seis meses: +70.42% (92.71)
Mudança de preço por ano: +144.02% (64.75)
Mudança de preço em 3 anos: +270.37% (42.66)
Mudança de preço em 5 anos: +1 384.26% (10.645)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 92.7 1
P/BV 53.32 1
P/E 180.83 1
EV/EBITDA 123.33 1
Total: 1

Eficiência

Nome Significado Nota
ROA, % 28.2 8
ROE, % 39.47 9
Total: 9.33

Dividendos

Nome Significado Nota
Div yield, % 0.4464 1.13
DSI 0.9286 9.29
Total: 5.24

Obrigação

Nome Significado Nota
Debt/EBITDA 0.025 10
Total: 9.6

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 92.61 9
Rentabilidade Ebitda, % 116.52 10
Rentabilidade EPS, % 142.43 10
Total: 7.8
Mais detalhes

Dividendo, % Dividendo Com base nos resultados do período Compre antes Data de encerramento do registro Pagamento antes
0.24% 0.15 II кв. 2024 02.09.2024 04.09.2024 19.09.2024
0.19% 0.12 IV кв. 2023 27.02.2024 29.02.2024 15.03.2024
Mais detalhes

Supervisor Cargo Pagamento Ano de nascimento
Dr. Sam Aaron Hupert M.B.B.S., M.D. Co-Founder, CEO, MD & Executive Director 724.12k
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc. Co-Founder, Technology Director & Executive Director 251.94k
Mr. Clayton James Hatch B.Comm, CPA, CPA Chief Financial Officer 279.15k
Dr. Malte Westerhoff GM of Europe & Global CTO 822.73k
Mr. Brad Levin GM of North America & Global Head of Marketing 261.78k
Ms. Sharni L. Redenbach People & Culture Director N/A
Mr. Sean Lambright Global Head of Sales - Visage Imaging Inc 801.7k
Ms. Teresa Gschwind Global Head of Customer Service of Visage Imaging Inc. N/A
Ms. Danny English C.A. Financial Controller & Company Secretary N/A

Endereço: Australia, Richmond. VIC, 450 Swan Street - abrir no Google Maps, abrir mapas Yandex
Site: https://www.promed.com.au